Nejvíce citovaný článek - PubMed ID 19826925
Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant)
Rheumatoid arthritis (RA) is a chronic inflammatory disease, leading to progressive destruction of joints and extra-articular tissues, including organs such as liver and spleen. The purpose of this study was to compare the effects of a potential immunomodulator, natural polyphenol N-feruloylserotonin (N-f-5HT), with methotrexate (MTX), the standard in RA therapy, in the chronic phase of adjuvant-induced arthritis (AA) in male Lewis rats. The experiment included healthy controls (CO), arthritic animals (AA), AA given N-f-5HT (AA-N-f-5HT), and AA given MTX (AA-MTX). N-f-5HT did not affect the body weight change and clinical parameters until the 14th experimental day. Its positive effect was rising during the 28-day experiment, indicating a delayed onset of N-f-5HT action. Administration of either N-f-5HT or MTX caused reduction of inflammation measured as the level of CRP in plasma and the activity of LOX in the liver. mRNA transcription of TNF-α and iNOS in the liver was significantly attenuated in both MTX and N-f-5HT treated groups of arthritic rats. Interestingly, in contrast to MTX, N-f-5HT significantly lowered the level of IL-1β in plasma and IL-1β mRNA expression in the liver and spleen of arthritic rats. This speaks for future investigations of N-f-5HT as an agent in the treatment of RA in combination therapy with MTX.
- MeSH
- arachidonátlipoxygenasy genetika metabolismus MeSH
- artritida experimentální farmakoterapie genetika patologie MeSH
- biologické markery MeSH
- C-reaktivní protein MeSH
- časové faktory MeSH
- cytokiny krev genetika metabolismus MeSH
- játra účinky léků metabolismus MeSH
- krysa rodu Rattus MeSH
- mediátory zánětu * MeSH
- methotrexát farmakologie MeSH
- modely nemocí na zvířatech MeSH
- orgánová specificita MeSH
- regulace genové exprese účinky léků MeSH
- serotonin analogy a deriváty farmakologie MeSH
- stupeň závažnosti nemoci MeSH
- transkriptom * MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- arachidonátlipoxygenasy MeSH
- biologické markery MeSH
- C-reaktivní protein MeSH
- cytokiny MeSH
- mediátory zánětu * MeSH
- methotrexát MeSH
- N-feruloylserotonin MeSH Prohlížeč
- serotonin MeSH
Metagenomic approaches are currently being used to decipher the genome of the microbiota (microbiome), and, in parallel, functional studies are being performed to analyze the effects of the microbiota on the host. Gnotobiological methods are an indispensable tool for studying the consequences of bacterial colonization. Animals used as models of human diseases can be maintained in sterile conditions (isolators used for germ-free rearing) and specifically colonized with defined microbes (including non-cultivable commensal bacteria). The effects of the germ-free state or the effects of colonization on disease initiation and maintenance can be observed in these models. Using this approach we demonstrated direct involvement of components of the microbiota in chronic intestinal inflammation and development of colonic neoplasia (i.e., using models of human inflammatory bowel disease and colorectal carcinoma). In contrast, a protective effect of microbiota colonization was demonstrated for the development of autoimmune diabetes in non-obese diabetic (NOD) mice. Interestingly, the development of atherosclerosis in germ-free apolipoprotein E (ApoE)-deficient mice fed by a standard low-cholesterol diet is accelerated compared with conventionally reared animals. Mucosal induction of tolerance to allergen Bet v1 was not influenced by the presence or absence of microbiota. Identification of components of the microbiota and elucidation of the molecular mechanisms of their action in inducing pathological changes or exerting beneficial, disease-protective activities could aid in our ability to influence the composition of the microbiota and to find bacterial strains and components (e.g., probiotics and prebiotics) whose administration may aid in disease prevention and treatment.
- MeSH
- autoimunitní nemoci etiologie mikrobiologie MeSH
- gastrointestinální trakt mikrobiologie MeSH
- gnotobiologické modely * MeSH
- imunita MeSH
- lidé MeSH
- metagenom imunologie MeSH
- modely nemocí na zvířatech MeSH
- nádory etiologie mikrobiologie MeSH
- sliznice imunologie MeSH
- zánět etiologie mikrobiologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH